Corona today: New drugs that fight the virus … and an additional danger threatening the

0
6


4:00 pm

Saturday 17 October 2020

Books – Sayed Metwally

After the new Corona virus has become a threat to the whole world about 9 months ago, its appearance, all of us are looking forward to know what happens every minute, in light of the tremendous development that Covid-19 has brought in our lives.

Within this framework, “Masrawy” provides a daily service that includes displaying everything you want to know about the latest developments in the emerging corona virus, from the emergence of new symptoms or the occurrence of a different mutation, as well as the development of vaccines and drugs, in brief.

Good news for less than 70 years

With the increasing number of new victims of the Corona virus in the world, a new study gave good news to everyone under the age of 70 and at risk of contracting COVID-19.

According to the study, only 0.05% of healthy people under the age of 70 who develop Covid-19 are at risk of dying from the disease, as published by the British newspaper The Daily Mail.

The research confirms that the Corona virus may kill only one out of 2,000 healthy people under the age of 70, which is very promising.

Dr. John Ianides, the epidemiologist who conducted the study, from Stanford University, confirms that the infection mortality rate could be as high as 0.05 percent in a review of antibody control studies.

New drugs that fight the virus

University of New Mexico researchers, who have researched a number of previously approved drugs, believe that they have identified a drug that would help speed up a patient’s recovery from SARS-CoV-2 infection, the virus that causes Corona.

According to “medicalxpress”, an old antimalarial drug called amodiaquine was effective in eradicating the Corona virus in test tube experiments.

Theodore Oprah, author of the new research, said that the other two drugs, an antipsychotic called zuclofentexol, and a blood pressure medication called nebivolol, eliminated the Corona virus in the experiments, as researchers believe that any of these three drugs can be combined with remdesivir or an anti-viral drug called faviravir. To launch a stronger attack on COVID-19.

The researcher added that the combination of two drugs can mean that lower doses of each can be given, which reduces the possibility of negative reactions, and the use of two drugs reduces the possibility of the virus developing a mutation that makes it immune to treatment.

Of blood type .. those who are least likely to have a corona infection

Two studies published in the journal “Blood Advances” revealed that people with blood type “AB0” (Group A) are less likely to be infected with the Coronavirus.

According to the two studies, Danish experts compared the data of more than 473,000 people who were examined for the detection of the Corona virus (Covid-19), and the results showed that among those who were found to be carriers of the virus, there were fewer patients with blood type AB0 (the first group) and more. From that with A (second), B (third) and AB (fourth)., According to Russia Today.

An additional risk of COVID-19 could be life-threatening

Researchers say that having the flu or coronavirus can increase the odds of stroke, the type in which blood flow in the brain is blocked.

And while the number of people affected by this condition may be small, understanding the dynamics can help everyone protect themselves, according to Russia Today.

Dr. Mitchell Elkind, professor of neuroscience and epidemiology at Columbia University in New York City, said when a stroke strikes a person with influenza or “Covid-19”, it can be the culmination of a long process.

“Long-term risk factors include high blood pressure, diabetes, smoking, cholesterol levels, failure to exercise and malnutrition,” said Elkind, president of the American Heart Association. These factors can pave the way for blood vessel blockage by a clot or the accumulation of fat called plaque.

LEAVE A REPLY

Please enter your comment!
Please enter your name here